EPISODE · Mar 13, 2019 · 42 MIN
#17. Appen's acquisition, Advance NanoTek, Clinuval Pharmaceuticals and more!
from Three Wise Monkeys Podcast · host Three Wise Monkeys
This week, we dissect Appen's latest acquisition and touch on the ethics of AI. We look to why shares in Envirosuite have surged higher, and ask whether the phenomenal gains from Clinuvel Pharmaceuticals and Advance NanoTek can continue. Plus Matt updates us on his recent meeting with the PushPay team. For more great content, please visit us at www.strawman.com, www.mattjoass.com & www.ethicalequities.com.au Email us at [email protected] And find us on Twitter @sage_simian @mattjoass @claudedwalker
What this episode covers
This week, we dissect Appen's latest acquisition and touch on the ethics of AI. We look to why shares in Envirosuite have surged higher, and ask whether the phenomenal gains from Clinuvel Pharmaceuticals and Advance NanoTek can continue. Plus Matt updates us on his recent meeting with the PushPay team. For more great content, please visit us at www.strawman.com, www.mattjoass.com & www.ethicalequities.com.au Email us at [email protected] And find us on Twitter @sage_simian @mattjoass @claudedwalker
NOW PLAYING
#17. Appen's acquisition, Advance NanoTek, Clinuval Pharmaceuticals and more!
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Jan 2, 2026 ·47m
Dec 21, 2025 ·46m